Neurocrine
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurocrine and other ETFs, options, and stocks.About NBIX
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids.
NBIX Key Statistics
Stock Snapshot
The current Neurocrine(NBIX) stock price is $131.13, with a market capitalization of 13.16B. The stock trades at a price-to-earnings (P/E) ratio of 28.08.
On 2026-03-26, Neurocrine(NBIX) stock traded between a low of $128.98 and a high of $132.98. Shares are currently priced at $131.13, which is +1.7% above the low and -1.4% below the high.
The Neurocrine(NBIX)'s current trading volume is 1.1M, compared to an average daily volume of 1.03M.
During the past year, Neurocrine(NBIX) stock moved between $84.23 at its lowest and $160.18 at its peak.
During the past year, Neurocrine(NBIX) stock moved between $84.23 at its lowest and $160.18 at its peak.
NBIX News
Neurocrine Biosciences (NBIX) is drawing attention after recent trading left the shares about 13% lower over the past 3 months and roughly 9% lower year to date...
Analyst ratings
84%
of 31 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.